October 20, 2008
(Date of earliest event reported)
LABORATORY CORPORATION
OF
AMERICA HOLDINGS
DELAWARE | 1-11353 | 13-3757370 | ||
(State or other jurisdiction of Incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
358 SOUTH MAIN STREET, BURLINGTON, NORTH CAROLINA |
27215 | 336-229-1127 | ||
(Address of principal executive offices) | (Zip Code) |
(Registrant's telephone number including area code) |
ITEM 7.01. Regulation FD Disclosure
On October 20, 2008, Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) (the Company) responded to the Food and Drug Administration's warning letter issued to LabCorp® dated September 29, 2008. A copy of the letter of response by the Company is attached as Exhibit 99.1.
Exhibits
99.1 Letter of Response by Laboratory Corporation of America to the Food and Drug Administration dated October 20, 2008
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Laboratory Corporation of America Holdings (Registrant) |
||||
Date: October 20, 2008 | By: | /s/F. Samuel Eberts III | ||
F. Samuel Eberts III, Senior Vice President and Assistant Secretary |
||||